The research is intended to address a knowledge gap on the use of tranexamic acid, a drug that is currently used in the majority of patients undergoing hip and knee replacement surgery. The current study adds weight to the conclusion of smaller prior studies that show there is no evidence suggesting the drug carries more complications in high-risk patients.
Source: Pharmacy Times
